Evidence map›Paper›PMID 35744852›Full record

SynthesisMolecules (Basel, Switzerland)2022

PET Imaging of the Neuropeptide Y System: A Systematic Review.

Inês C F Fonseca, Miguel Castelo-Branco, Cláudia Cavadas, Antero J Abrunhosa

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Heterobivalent Dual-Target Peptide for Integrin-αPharmaceuticals (Basel, Switzerland) · 2024
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Inês C F FonsecaCIBIT/ICNAS-Institute for Nuclear Sciences Applied to Health, University of Coimbra, 3000-548 Coimbra, Portugal.
Miguel Castelo-BrancoCIBIT/ICNAS-Institute for Nuclear Sciences Applied to Health, University of Coimbra, 3000-548 Coimbra, Portugal.
Cláudia CavadasFaculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
Antero J AbrunhosaCIBIT/ICNAS-Institute for Nuclear Sciences Applied to Health, University of Coimbra, 3000-548 Coimbra, Portugal.ORCID 0000-0002-4145-854X
University of Coimbra · PT

Funding

Fundação para a Ciência e Tecnologia UIDB/04539/2020, UIDP/04539/2020, UIDB/4950/2020, UIDP/4950/2020, PD/BDE/150334/2019
6 · The paper itself

Abstract

Neuropeptide Y (NPY) is a vastly studied biological peptide with numerous physiological functions that activate the NPY receptor family (Y

Indexed as

Neuropeptide YReceptors, Neuropeptide YPositron-Emission TomographyNeuropeptide YReceptors, Neuropeptide Yneuroimagingneuropeptide YNPY receptorsPET radiotracerspositron emission tomography

Identifiers

PMID35744852
PMCPMC9227365
OpenAlexW4282591294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.